
Company Number
07883194
Next Accounts
Sep 2025
Shareholders
scope opthalmics ltd
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
unit 4 amberley court, county oak way, crawley, RH11 7XL
Website
www.scopeophthalmics.comPomanda estimates the enterprise value of SCOPE OPHTHALMICS LIMITED at £44.2m based on a Turnover of £46.6m and 0.95x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SCOPE OPHTHALMICS LIMITED at £7.9m based on an EBITDA of £901.9k and a 8.81x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SCOPE OPHTHALMICS LIMITED at £15.1m based on Net Assets of £8m and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Scope Ophthalmics Limited is a live company located in crawley, RH11 7XL with a Companies House number of 07883194. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in December 2011, it's largest shareholder is scope opthalmics ltd with a 100% stake. Scope Ophthalmics Limited is a established, large sized company, Pomanda has estimated its turnover at £46.6m with high growth in recent years.
Pomanda's financial health check has awarded Scope Ophthalmics Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
4 Regular
3 Weak
Size
annual sales of £46.6m, make it larger than the average company (£24.7m)
£46.6m - Scope Ophthalmics Limited
£24.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 17%, show it is growing at a faster rate (5.3%)
17% - Scope Ophthalmics Limited
5.3% - Industry AVG
Production
with a gross margin of 29.7%, this company has a comparable cost of product (29.5%)
29.7% - Scope Ophthalmics Limited
29.5% - Industry AVG
Profitability
an operating margin of 1.9% make it less profitable than the average company (4.1%)
1.9% - Scope Ophthalmics Limited
4.1% - Industry AVG
Employees
with 74 employees, this is above the industry average (36)
74 - Scope Ophthalmics Limited
36 - Industry AVG
Pay Structure
on an average salary of £83.7k, the company has an equivalent pay structure (£81.5k)
£83.7k - Scope Ophthalmics Limited
£81.5k - Industry AVG
Efficiency
resulting in sales per employee of £629.4k, this is equally as efficient (£661.5k)
£629.4k - Scope Ophthalmics Limited
£661.5k - Industry AVG
Debtor Days
it gets paid by customers after 58 days, this is near the average (58 days)
58 days - Scope Ophthalmics Limited
58 days - Industry AVG
Creditor Days
its suppliers are paid after 131 days, this is slower than average (30 days)
131 days - Scope Ophthalmics Limited
30 days - Industry AVG
Stock Days
it holds stock equivalent to 115 days, this is more than average (65 days)
115 days - Scope Ophthalmics Limited
65 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 14 weeks, this is more cash available to meet short term requirements (11 weeks)
14 weeks - Scope Ophthalmics Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 75.9%, this is a higher level of debt than the average (54.4%)
75.9% - Scope Ophthalmics Limited
54.4% - Industry AVG
Scope Ophthalmics Limited's latest turnover from December 2023 is £46.6 million and the company has net assets of £8 million. According to their latest financial statements, Scope Ophthalmics Limited has 74 employees and maintains cash reserves of £6.9 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 46,576,345 | 42,445,883 | 34,389,713 | 29,428,255 | 29,287,335 | 23,696,188 | 19,043,810 | 14,390,784 | 10,857,565 | |||
Other Income Or Grants | ||||||||||||
Cost Of Sales | 32,768,365 | 29,417,655 | 24,464,427 | 20,809,787 | 21,010,037 | 16,600,461 | 13,009,948 | 8,695,263 | 6,478,880 | |||
Gross Profit | 13,807,980 | 13,028,228 | 9,925,286 | 8,618,468 | 8,277,298 | 7,095,727 | 6,033,862 | 5,695,521 | 4,378,685 | |||
Admin Expenses | 12,906,105 | 11,375,915 | ||||||||||
Operating Profit | 901,875 | 1,652,313 | ||||||||||
Interest Payable | ||||||||||||
Interest Receivable | 57,419 | 14,814 | ||||||||||
Pre-Tax Profit | 959,294 | 1,667,127 | 2,595,122 | 1,860,715 | 1,611,300 | 778,733 | 323,045 | 88,671 | 35,156 | |||
Tax | -238,328 | -328,737 | -502,311 | -352,840 | -311,889 | -151,132 | -70,445 | -22,006 | -10,436 | |||
Profit After Tax | 720,966 | 1,338,390 | 2,092,811 | 1,507,875 | 1,299,411 | 627,601 | 252,600 | 66,665 | 24,720 | |||
Dividends Paid | ||||||||||||
Retained Profit | 720,966 | 1,338,390 | 2,092,811 | 1,507,875 | 1,299,411 | 627,601 | 252,600 | 66,665 | 24,720 | |||
Employee Costs | 6,190,944 | 5,281,468 | 4,000,329 | 3,450,336 | 3,241,502 | 3,243,861 | 2,807,721 | 2,786,861 | 2,060,660 | |||
Number Of Employees | 74 | 74 | 76 | 71 | 62 | 62 | 55 | 56 | 33 | |||
EBITDA* | 901,875 | 1,652,313 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 22,688 | 36,564 | 50,442 | 7,603 | 10,138 | |||||||
Intangible Assets | 4,103 | 4,103 | 4,103 | 4,103 | 4,103 | |||||||
Investments & Other | ||||||||||||
Debtors (Due After 1 year) | ||||||||||||
Total Fixed Assets | 4,103 | 4,103 | 4,103 | 4,103 | 26,791 | 36,564 | 50,442 | 7,603 | 10,138 | |||
Stock & work in progress | 10,354,649 | 10,144,259 | 5,121,702 | 6,998,026 | 6,866,281 | 3,816,628 | 2,852,693 | 1,231,557 | 1,570,051 | 706,227 | 1,032,250 | 579,076 |
Trade Debtors | 7,429,094 | 9,205,418 | 6,588,466 | 6,282,142 | 4,768,931 | 4,590,943 | 4,157,882 | 2,957,812 | 2,655,425 | 2,161,524 | 1,346,265 | 778,911 |
Group Debtors | 7,802,757 | 6,722,870 | 4,331,319 | 2,878,388 | 1,481,153 | |||||||
Misc Debtors | 695,935 | 285,246 | 171,074 | 172,142 | 521,504 | 301,609 | 257,800 | 554,197 | 81,887 | |||
Cash | 6,935,453 | 2,759,536 | 6,795,004 | 3,579,388 | 1,879,165 | 1,969,070 | 437,716 | 188,155 | 91,951 | 538,143 | 209,175 | 61,744 |
misc current assets | ||||||||||||
total current assets | 33,217,888 | 29,117,329 | 23,007,565 | 19,910,086 | 15,517,034 | 10,678,250 | 7,706,091 | 4,931,721 | 4,399,314 | 3,405,894 | 2,587,690 | 1,419,731 |
total assets | 33,217,888 | 29,117,329 | 23,011,668 | 19,914,189 | 15,521,137 | 10,682,353 | 7,732,882 | 4,968,285 | 4,449,756 | 3,413,497 | 2,597,828 | 1,419,731 |
Bank overdraft | 1,491 | |||||||||||
Bank loan | ||||||||||||
Trade Creditors | 11,834,145 | 9,266,813 | 5,437,011 | 4,255,857 | 5,086,885 | 3,528,013 | 3,226,491 | 2,239,864 | 1,731,564 | |||
Group/Directors Accounts | 10,532,571 | 10,570,739 | 1,877,385 | |||||||||
other short term finances | ||||||||||||
hp & lease commitments | ||||||||||||
other current liabilities | 2,852,152 | 2,001,723 | 11,634,993 | 11,811,479 | 8,095,274 | 6,114,773 | 4,094,425 | 2,569,055 | 746,615 | 3,345,516 | 2,563,855 | 1,406,570 |
total current liabilities | 25,218,868 | 21,839,275 | 17,072,004 | 16,067,336 | 13,182,159 | 9,642,786 | 7,320,916 | 4,808,919 | 4,357,055 | 3,345,516 | 2,563,855 | 1,406,570 |
loans | ||||||||||||
hp & lease commitments | ||||||||||||
Accruals and Deferred Income | ||||||||||||
other liabilities | ||||||||||||
provisions | ||||||||||||
total long term liabilities | ||||||||||||
total liabilities | 25,218,868 | 21,839,275 | 17,072,004 | 16,067,336 | 13,182,159 | 9,642,786 | 7,320,916 | 4,808,919 | 4,357,055 | 3,345,516 | 2,563,855 | 1,406,570 |
net assets | 7,999,020 | 7,278,054 | 5,939,664 | 3,846,853 | 2,338,978 | 1,039,567 | 411,966 | 159,366 | 92,701 | 67,981 | 33,973 | 13,161 |
total shareholders funds | 7,999,020 | 7,278,054 | 5,939,664 | 3,846,853 | 2,338,978 | 1,039,567 | 411,966 | 159,366 | 92,701 | 67,981 | 33,973 | 13,161 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||
Operating Profit | 901,875 | 1,652,313 | ||||||||||
Depreciation | 22,688 | 13,876 | 13,878 | |||||||||
Amortisation | ||||||||||||
Tax | -238,328 | -328,737 | -502,311 | -352,840 | -311,889 | -151,132 | -70,445 | -22,006 | -10,436 | |||
Stock | 210,390 | 5,022,557 | -1,876,324 | 131,745 | 3,049,653 | 963,935 | 1,621,136 | -338,494 | 863,824 | -326,023 | 453,174 | 579,076 |
Debtors | -285,748 | 5,122,675 | 1,758,187 | 2,561,084 | 1,879,036 | 476,870 | 903,673 | 774,697 | 575,788 | 815,259 | 567,354 | 778,911 |
Creditors | 2,567,332 | 3,829,802 | 1,181,154 | -831,028 | 1,558,872 | 301,522 | 986,627 | 508,300 | 1,731,564 | |||
Accruals and Deferred Income | 850,429 | -9,633,270 | -176,486 | 3,716,205 | 1,980,501 | 2,020,348 | 1,525,370 | 1,822,440 | -2,598,901 | 781,661 | 1,157,285 | 1,406,570 |
Deferred Taxes & Provisions | ||||||||||||
Cash flow from operations | 4,156,666 | -14,625,124 | ||||||||||
Investing Activities | ||||||||||||
capital expenditure | -56,717 | |||||||||||
Change in Investments | ||||||||||||
cash flow from investments | -56,717 | |||||||||||
Financing Activities | ||||||||||||
Bank loans | ||||||||||||
Group/Directors Accounts | -38,168 | 10,570,739 | -1,877,385 | 1,877,385 | ||||||||
Other Short Term Loans | ||||||||||||
Long term loans | ||||||||||||
Hire Purchase and Lease Commitments | ||||||||||||
other long term liabilities | ||||||||||||
share issue | ||||||||||||
interest | 57,419 | 14,814 | ||||||||||
cash flow from financing | 19,251 | 10,585,553 | -1,877,385 | 1,877,385 | ||||||||
cash and cash equivalents | ||||||||||||
cash | 4,175,917 | -4,035,468 | 3,215,616 | 1,700,223 | -89,905 | 1,531,354 | 249,561 | 96,204 | -446,192 | 328,968 | 147,431 | 61,744 |
overdraft | -1,491 | 1,491 | ||||||||||
change in cash | 4,175,917 | -4,035,468 | 3,215,616 | 1,700,223 | -89,905 | 1,531,354 | 249,561 | 97,695 | -447,683 | 328,968 | 147,431 | 61,744 |
Perform a competitor analysis for scope ophthalmics limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other large companies, companies in RH11 area or any other competitors across 12 key performance metrics.
SCOPE OPHTHALMICS LIMITED group structure
Scope Ophthalmics Limited has no subsidiary companies.
Ultimate parent company
SCOPE OPHTHALMICS LIMITED
07883194
Scope Ophthalmics Limited currently has 2 directors. The longest serving directors include Mr Tom Freyne (Dec 2011) and Mr Laurence Dunne (Aug 2016).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Tom Freyne | Ireland | 41 years | Dec 2011 | - | Director |
Mr Laurence Dunne | Ireland | 56 years | Aug 2016 | - | Director |
P&L
December 2023turnover
46.6m
+10%
operating profit
901.9k
-45%
gross margin
29.7%
-3.41%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
8m
+0.1%
total assets
33.2m
+0.14%
cash
6.9m
+1.51%
net assets
Total assets minus all liabilities
company number
07883194
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
December 2011
age
14
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
HUGH MCCARTHY & ASSOCIATES
address
unit 4 amberley court, county oak way, crawley, RH11 7XL
Bank
BARCLAYS BANK PLC
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to scope ophthalmics limited. Currently there are 1 open charges and 1 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SCOPE OPHTHALMICS LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|